Russia In Vitro Fertilization (IVF) Market is expected to garner $641 Million by 2022

"Fertility clinics and hospitals collectively contributed about three-fourths of the market revenue in 2014. This is attributed to their crucial role in providing technologically advanced IVF treatment to couples seeking assistance for infertility treatment."

Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/2389

According to a new report published by Allied Market Research, titled, "Russia In Vitro Fertilization by End User, Cycle Type, Type, Drug, and Mode of Administration: Opportunity Analysis and Industry Forecast, 2014-2022," the Russia IVF market was valued at $398 million in 2015, and is projected to reach $641 million by 2022, growing at a CAGR of 7.0% from 2016 to 2022. Non-assisted IVF cycles are projected to witness the highest growth rate from 2016 to 2022.

In Vitro Fertilization (IVF) is an assisted reproductive technology (ART) that forms embryos in a laboratory environment by extraction of eggs, sampling of sperm cells, and manual combination of eggs and sperm. The embryo is then transferred to the female womb for subsequent pregnancy.

The Russian IVF market is dominated by an increase in the incidence of infertility cases, a delayed pregnancy trend among women, technological advances in IVF procedures and increased spouse donations. However, insufficient reimbursement policies in relation to IVF treatment are expected to hamper this growth. In addition, increased interest in single parent and same-sex couples experiencing parental roles through ART, particularly IVF, is expected to provide a variety of opportunities for market development.

The fertility clinics segment accounted for the highest share of the Russia IVF end user market in 2015, owing to the availability of wide range of fertility treatments under a single roof and applicable government reimbursements. The donor egg IVF cycle type segment is anticipated to witness the highest growth rate from 2016 to 2022. However, the fresh cycle (non-donor) is projected to dominate the cycle type market.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/2389

At present, gonadotropins & gonadotropin-releasing hormones dominate the drug segment of the market, and is expected to grow at a CAGR of 6.5% during the forecast period. This is attributable to the effectiveness and safety of this drug to stimulate ovulation during an IVF procedure.

Key Findings of the Russia in Vitro Fertilization (IVF) Market:

• The fertility clinics end-user segment is anticipated to grow at the highest CAGR from 2016 to 2022 in terms of value as well as volume.
• The fresh IVF cycle (non-donor) cycle type segment generated the highest revenue in 2015, and is expected to continue its dominance in the near future.
• ICSI assisted IVF cycles dominated the Russia IVF market, and are projected to grow at a CAGR of 6.4%.
• Donor egg IVF cycle type is expected to witness the highest growth rate in terms of value as well as volume during the forecast period.

The major companies profiled in the report include Ava-Peter Clinic, MD Medical Group, and IVF Russia (The International Centre of the Reproductive Medicines).

For More Details on this Report visit @ https://www.alliedmarketresearch.com/russia-in-vitro-fertilization-IVF-market

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.